Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vbi Vaccines Inc CS (VBIV)

3.64   -0.12 (-3.19%) 08-14 16:00
Open: 3.74 Pre. Close: 3.76
High: 3.7847 Low: 3.505
Volume: 4,014,585 Market Cap: 842M
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology in Israel, the United States, and internationally. The company offers Sci-B-Vac, a prophylactic hepatitis B vaccine for adults, children, and newborns. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for a functional cure of chronic hepatitis B. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the target virus to elicit a potent immune response. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.791 - 3.812 3.812 - 3.829
Low: 3.448 - 3.476 3.476 - 3.499
Close: 3.597 - 3.64 3.64 - 3.676

Technical analysis

as of: 2020-08-14 4:35:23 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 6.48     One year: 8.09
Support: Support1: 3.31    Support2: 2.75
Resistance: Resistance1: 5.55    Resistance2: 6.93
Pivot: 4.10
Moving Average: MA(5): 3.74     MA(20): 4.46
MA(100): 2.58     MA(250): 1.59
MACD: MACD(12,26): -0.06     Signal(9): 0.11
Stochastic oscillator: %K(14,3): 15.41     %D(3): 11.33
RSI: RSI(14): 43.89
52-week: High: 6.93  Low: 0.47  Change(%): 453.8
Average Vol(K): 3-Month: 1306143  10-Days: 828492

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
VBIV has closed above bottom band by 17.6%. Bollinger Bands are 0.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 05 Aug 2020
PREVIEW-Golf-A PGA Championship like no other comes to San Francisco - Nasdaq

Wed, 05 Aug 2020
BUZZ-U.S. STOCKS ON THE MOVE-Oasis Petroleum, Humana, Triumph Group, Teladoc Health - Nasdaq

Wed, 05 Aug 2020
Bolsonaro says Brazil will send help to blast-stricken Lebanon - Nasdaq

Wed, 05 Aug 2020
Wall Street gains on Disney's surprise profit, fiscal aid hopes -

Wed, 15 Apr 2020
VBI Vaccines - Consenus Indicates Potential 650.0% Upside - DirectorsTalk Interviews

Thu, 05 Sep 2019
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 231
Shares Float (M) 150
% Held by Insiders 5.26
% Held by Institutions 44.45
Shares Short (K) 10,880
Shares Short P. Month (K) 6,500

Stock Financials

EPS -0.350
EPS Est This Year -0.890
EPS Est Next Year -1.010
Book Value (p.s.) 0.420
Profit Margin
Operating Margin -1832.21
Return on Assets (ttm) -22.3
Return on Equity (ttm) -60.3
Qtrly Rev. Growth 15.3
Gross Profit (p.s.) -0.025
Sales Per Share 0.010
EBITDA (p.s.) -0.174
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) -30

Stock Valuations

PE Ratio -10.40
PEG Ratio
Price to Book value 8.67
Price to Sales 368.23
Price to Cash Flow -19.83

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2012-12-27
Ex-Dividend Date 2012-02-04
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.